Authors
Latest:
The Challenge of Market Uptake for BiosimilarsAs more originator biologics lose patent exclusivity in the next decade, a healthy biosimilars pipeline is necessary but requires market support.
Latest:
End-to-End Cell Therapy Automation: An Immunotherapy Case StudyConsider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Latest:
End-to-End Cell Therapy Automation: An Immunotherapy Case StudyConsider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Latest:
End-to-End Cell Therapy Automation: An Immunotherapy Case StudyConsider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Latest:
Improving Aggregate Removal to Enhance Clinical Manufacturing of MAbsHydrophobic interaction chromatography (HIC) in flow-through mode offers a more efficient and cost-effective polishing/purification process to remove monoclonal antibody aggregates while maintaining purity at ≥99% than a mixed-mode bind/elute procedure.
Latest:
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesA case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Latest:
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesA case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Latest:
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesA case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Latest:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryUsing a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Latest:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryUsing a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Latest:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryUsing a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Latest:
Accelerating Genetic Medicine R&D Using MicrofluidicsThis review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Latest:
Accelerating Genetic Medicine R&D Using MicrofluidicsThis review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Latest:
Accelerating Genetic Medicine R&D Using MicrofluidicsThis review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Latest:
Accelerating Genetic Medicine R&D Using MicrofluidicsThis review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Latest:
Thermal Protection for Control-Room-Temperature ProductsThe authors discuss how to develop a cost-effective thermally protective packaging system.
Latest:
Control Viral Contaminants with Effective TestingDetecting viral contaminants in biologic-based medicines-and identifying their source-requires a holistic testing approach.
Latest:
Optimizing Protein Aggregate Analysis by SECA UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
Latest:
Optimizing Protein Aggregate Analysis by SECA UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
Latest:
Optimizing Protein Aggregate Analysis by SECA UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Development of Purification for Challenging Fc-Fusion ProteinsThis study outlines methods for an alternative protein-polishing process for challenging proteins.
Latest:
Molecular Cloning, Expression, and Purification of a Recombinant Fusion Protein (rNT-gp96-NT300). This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Latest:
Molecular Cloning, Expression, and Purification of a Recombinant Fusion Protein (rNT-gp96-NT300). This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Latest:
Molecular Cloning, Expression, and Purification of a Recombinant Fusion Protein (rNT-gp96-NT300). This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Latest:
Molecular Cloning, Expression, and Purification of a Recombinant Fusion Protein (rNT-gp96-NT300). This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
